Examines the pharmacokinetic parameters, physiological processes and developmental differences in children and adults that determine optimal dose and dosing intervals in the management of child and adolescent mental illness, with details of efficacy, potency and side effects of …
Covering social, ethical, and legal issues surrounding the administration of psychostimulants and antidepressants, this book presents guidelines for pharmacological intervention in childhood and adolescent psychiatric disorders. Incorporating the results of studies done on speci…
Global mental health trials
"Global mental health is a dynamic field of global health; a core aspect of the story which has led to its emergence has been the conduct of randomised controlled trials (RCTs) evaluating innovative delivery systems of packages of care for mental disorders in low-resource settin…
When the first edition of Pediatric Psychopharmacology published in 2002, it filled a void in child and adolescent psychiatry and quickly establishing itself as the definitive text-reference in pediatric psychopharmacology. While numerous short, clinically focused paperbacks hav…
When the first edition of Pediatric Psychopharmacology published in 2002, it filled a void in child and adolescent psychiatry and quickly establishing itself as the definitive text-reference in pediatric psychopharmacology. While numerous short, clinically focused paperbacks hav…
When the first edition of Pediatric Psychopharmacology published in 2002, it filled a void in child and adolescent psychiatry and quickly establishing itself as the definitive text-reference in pediatric psychopharmacology. While numerous short, clinically focused paperbacks hav…
Cannabinoids in neurologic and mental disease
Cannabinoids in neurologic and mental disease
Cannabinoids in neurologic and mental disease
Cannabinoids in neurologic and mental disease
The application of cannabis sativa for the treatment of neurologic and mental disease is expanding. Cannabinoids in Neurologic and Mental Disease collects and presents for the first time recent research involving the use of pharmacological cannabinoids for the treatment of neuro…
Polypharmacy in psychiatry practice
Although monotherapy is generally recommended as the treatment of choice, treatment resistance of patients with psychosis, cognitive, mood and anxiety disorders represents a significant clinical problem. In this context, augmentation and combination strategies are commonly emplo…
Polypharmacy in psychiatry practice
"Antipsychotic (neuroleptic) drugs have become some of the biggest blockbusters of the early 21st century, increasingly prescribed not just to people with 'schizophrenia' or other severe forms of mental disturbance but for a range of more common psychological complaints. This bo…